
Legal
Latest News

Private equity investment in health care the focus of upcoming FTC public workshop
Latest Videos

More News

It seems like the U.S. government has officially given up on the idea of physician-led primary care.

Representatives consider reauthorization of ‘Dr. Lorna Breen Health Care Provider Protection Act.’

Study reveals disparities in EMS care across urban and rural communities

The top news stories in medicine today.

Change takes effect in 2025 and could benefit more than one million Medicare beneficiaries

How do we balance AI's potential for advancing medical research against the need to safeguard the privacy of individuals' health information?

Experts weigh in on regulations needed as health leaders integrate artificial intelligence into patient care.

MGMA publishes its 2024 Advocacy Agenda with position paper on artificial intelligence included for the first time.

Intervention at the primary care level on housing issues may be beneficial for disadvantaged patients, research shows

A new advocacy organization for independent physicians.

Amount patients need to save to cover all expenses continues to rise

Rule update will especially benefit rural and low-income patients

Is your practice following proper protocols when it comes to telehealth?

Are your employment agreements compliant with both state and federal law?

House lawmakers resume banging the drum for health care price transparency.

Nearly half of traditional Medicare beneficiaries now are aligned to an ACO


Better primary care could help reduce the disparities

New regulations aim to make prior auths faster and clearer for physicians and patients.

Warns of “access issues” if lawmakers fail to act

Congress must make faster prior authorizations a national priority in health care, advocates say.

Inflation is tops but health care concern is high as pessimism spreads like wildfire.

Collaboration among medical school, nursing school, and rural health institute aims to bring better care to rural Texas

HHS supports change from Schedule I drug to Schedule III, but DEA must weigh in.

Study finds majority takes less than three weeks, and many spend some vacation time working








